The use of a DNA vaccine against Asparaginyl Endopeptidase Legumain (which is overexpressed in TAMs) demonstrated a reduction in the number of TAMs in the TME of BC in syngeneic BALB/c mice and led to a decreased rate tumor growth, angiogenesis, and metastasis [89]. Here, LGMN is linked to breast cancer.